# An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

> **NCT05202366** · — · COMPLETED · sponsor: **CAGE Bio Inc.** · enrollment: 15 (actual)

## Conditions studied

- Fungal Infection
- Onychomycosis
- Tinea Unguium

## Interventions

- **DRUG:** CGB-400 Topical Gel

## Key facts

- **NCT ID:** NCT05202366
- **Lead sponsor:** CAGE Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-08
- **Primary completion:** 2024-08-08
- **Final completion:** 2024-08-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05202366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05202366, "An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05202366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*